Quick Takeaways
- Marella Thorell has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $468,813.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Marella Thorell
- Location
- Ambler, PA
- Summary
- The estimated net worth of Marella Thorell is at least $468,813 dollars as of 06 Mar 2026. Marella Thorell is the Chief Accounting Officer of Centessa Pharmaceuticals plc and owns shares of Centessa Pharmaceuticals plc (CNTA) stock worth about $422.7K. Marella Thorell is the Director of Vallon Pharmaceuticals, Inc. and owns shares of GRI Bio, Inc. (GRI) stock worth about $38.8K. Marella Thorell is the Chief Financial Officer of Evelo Biosciences, Inc. and owns shares of Evelo Biosciences, Inc. (EVLO) stock worth about $7.3K.
- Signature
- /s/ Thomas J. DesRosier, Attorney-in-Fact for Marella Thorell
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Marella Thorell and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Centessa Pharmaceuticals plc ($422,684).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Marella Thorell
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | Chief Accounting Officer | $422,684 | 21 Mar 2022 | ||
| GRI | Vallon Pharmaceuticals, Inc. | Director | $38,784 | 13 Dec 2022 | ||
| EVLO | Evelo Biosciences, Inc. | Chief Financial Officer | $7,345 | 07 Nov 2023 | ||
| EPIX | ESSA Pharma Inc. | Director | $0 | 09 Oct 2025 | ||
| CARM | Carisma Therapeutics Inc. | Director | 01 Jul 2024 | |||
| MCRB | Seres Therapeutics, Inc. | EVP and Chief Financial Officer | 04 Mar 2026 |
Insider Transactions Reported by Marella Thorell:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.